TKMR

Arbutus Biopharma Corporation

A clinical-stage biopharmaceutical company working toward a cure for chronic hepatitis B, developing therapies that attack the virus at different stages of its lifecycle. Founded in 2005 as Tekmira Pharmaceuticals, it took the name Arbutus in 2015 after combining with OnCore BioPharma. The name honors the arbutus, a North American plant long valued for its healing properties—a fitting symbol for a company devoted to restoring health.